HealthCare Middle East & Africa Magazine News-WEEK45

AFRICAN ?NEWS HEADLINES ?

Unitaid invests US$22M in Kenya’s medical oxygen production

KENYA— UNITAID has launched a transformative US$22 million initiative to address critical medical oxygen shortages in sub-Saharan Africa through its newly established East African Program on Oxygen Access (EAPOA). . .More

Pfizer delivers 1B doses of pneumococcal vaccine in collaboration with Gavi

ETHIOPIA—Pfizer has announced that it has supplied its one billionth dose of the pneumococcal conjugate vaccine (PCV) through its ongoing partnership with Gavi, the Vaccine Alliance. . .More

Madinet Masr partners with Baheya Hospital to combat breast cancer

EGYPT—Madinet Masr, a leading developer of urban communities in Egypt, has recently launched a significant corporate social responsibility (CSR) initiative in partnership with Baheya Hospital to support breast cancer fighters. . .More

Zimbabwe strengthens polio surveillance with new lab

ZIMBABWE—Zimbabwe has inaugurated a state-of-the-art laboratory that analyses polio samples collected through environmental surveillance (ES), marking a significant milestone in the country’s public health efforts. . .More

MIDDLE EAST NEWS HEADLINES ?

M42 welcomes Paul Jones?to lead Omics Centre of Excellence?

UAE—M42, a tech-driven leader in global healthcare innovation, has appointed Paul Jones as the Chief Executive Officer of its Omics Centre of Excellence in the UAE. . .More

King Faisal Specialist Hospital & Research Center pioneers personalized medicine in Saudi Arabia

SAUDI ARABIA?— King Faisal Specialist Hospital & Research Centre (KFSHRC) has made considerable progress in personalized medicine by conducting pharmacogenetic tests on over 1,500 patients. . .More

Cleveland Clinic Abu Dhabi pioneers renal denervation procedure to combat?resistant hypertension in UAE

UAE—Cleveland Clinic Abu Dhabi, part of the M42 group, has launched renal denervation, an innovative procedure for treating resistant hypertension. . .More

WORLD NEWS HEADLINES

AbbVie acquires Aliada Therapeutics for US$1.4B

USA—American pharmaceutical leader AbbVie has announced an acquisition agreement to purchase Aliada Therapeutics, a private biotech firm, for US$1.4 billion in cash. . .More

Naobios collaborates with Sumagen to scale up HIV vaccine production

FRANCE – Naobios, a CDMO specializing in bioprocess development and GMP production of virus-based products, has announced the bench-scale production of Sumagen Canada Inc.’s HIV-1 vaccine candidate. . .More

Editas Medicine partners with Genevant Sciences to develop gene-editing therapies

USA—Editas Medicine has announced a nonexclusive licensing partnership with Genevant Sciences to co-develop innovative gene-editing therapies. . .More

?